As of Nov 25
| +0.68 / +13.08%|
The 4 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 12.00. The median estimate represents a +138.10% increase from the last price of 5.88.
The current consensus among 4 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.